Management of four pregnant women with multidrug-resistant tuberculosis

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1298-1304

  Nitta, Annette Tsugie ^a,b,c,d   Milligan, Deborah ^a,b,c  

^a LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c St Mary's Medical Center   (United States)

^d Tuberculosis Control Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; FEMALE; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PREGNANCY; PRIORITY JOURNAL; SPUTUM CULTURE; SPUTUM SMEAR; TUBERCULOSIS;

EID: 0033045918     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514795     Document Type: Article

References (24)

1. 1. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144:745-9.
2. 2. Reichman L.B. The U-shaped curve of concern (editorial). Am Rev Respir Dis 1991; 144:741-2.
3. 3. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272: 535-9.
4. 4. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330:1179-84.
5. 5. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly-observed therapy for tuberculosis. JAMA 1995; 274: 945-51.
6. 6. Centers for Disease Control and Prevention. Tuberculosis morbidity - United States, 1996. MMWR Morb Mortal Wkly Rep 1997; 46: 695-700.
7. 7. Centers for Disease Control and Prevention. Tuberculosis among pregnant women - New York City, 1985-1992. MMWR Morb Mortal Wkly Rep 1993; 42:605, 611-12.
8. 8. Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr. Multidrug-resistant tuberculosis (editorial). Ann Intern Med 1992; 117:257-9.
9. 9. Good JT Jr, Iseman MD, Davidson PT, Lakshminarayan S, Sahn SA, Tuberculosis in association with pregnancy. Am J Obstet Gynecol 1981; 140:492-8.
10. 10. Schaefer G, Zervoudakis IA, Fuchs FF, David S. Pregnancy and pulmonary tuberculosis. Obstet Gynecol 1975; 46:706-15.
11. 11. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Morb Mortal Wkly Rep 1994; 43(RR-13):1-132.
12. 12. American Thoracic Society, Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149:1359-74.
13. 13. Goble M. Drug resistance. In: Friedman LN, ed. Tuberculosis: current concepts on treatment. Boca Raton, FL: CRC Press, 1994:259-84.
14. 14. Davidson PT, Le HQ. Drug treatment of tuberculosis - 1992. Drugs 1992; 43:651-73.
15. 15. Bjerkedal T, Bahna LB, Lehmann EH. Course and outcome of pregnancy in women with pulmonary tuberculosis. Scand J Respir Dis 1975; 56: 245-50.
16. 16. Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992; 101: 1114-20.
17. 17. Snider DE Jr, Layde PM, Johnson MW, Lyle MA. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980; 122:65-79.
18. 18. Nitta A, Davidson P, de Koning M, Knowles L. Multidrug-resisfant tuberculosis (MDR-TB) in Los Angeles County 8/93 to 8/94: a descriptive analysis [abstract]. Am J Respir Crit Care Med 1995; 151(suppl 2): A505.
19. 19. Girling DJ. The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis. Tubercle 1984; 65:1-4.
20. 20. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328:527-32.
21. 21. Advisory Council for the Elimination of Tuberculosis, Advisory Committee on Immunization Practices. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1996; 45(RR-4):1-18.
22. 22. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994; 271:698-702.
23. 23. Nitta AT, Davidson PT, de Koning ML, Kilman RJ. Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors. JAMA 1996; 276: 1980-3.
24. 24. Rossman MD, Mayock RL. Pulmonary tuberculosis. In: Schlossberg D, ed. Tuberculosis. 3rd ed. New York: Springer-Verlag, 1994:95-106.